Prudential Financial Inc Spero Therapeutics, Inc. Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.35 - $1.79 $3,780 - $5,012	-2,800 Reduced 9.93%	25,400 $43,000
Q3 2023 Nov 13, 2023	BUY	$1.2 - $1.63 $4,560 - $6,194	3,800 Added 15.57%	28,200 $34,000
Q2 2023 Aug 11, 2023	BUY	$1.42 - $1.95 $34,648 - $47,580	24,400 New	24,400 $35,000
Q4 2022 Feb 14, 2023	BUY	$1.55 - $2.12 $22,630 - $30,952	14,600 New	14,600 $0

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.